Ambient fine particulate air pollution triggers ST-elevation myocardial infarction, but not non-ST elevation myocardial infarction: a case-crossover study

Blake Gardner, Frederick Ling, Philip K Hopke, Mark W Frampton, Mark J Utell, Wojciech Zareba, Scott J Cameron, David Chalupa, Cathleen Kane, Suresh Kulandhaisamy, Michael C Topf, David Q Rich, Blake Gardner, Frederick Ling, Philip K Hopke, Mark W Frampton, Mark J Utell, Wojciech Zareba, Scott J Cameron, David Chalupa, Cathleen Kane, Suresh Kulandhaisamy, Michael C Topf, David Q Rich

Abstract

Background: We and others have shown that increases in particulate air pollutant (PM) concentrations in the previous hours and days have been associated with increased risks of myocardial infarction, but little is known about the relationships between air pollution and specific subsets of myocardial infarction, such as ST-elevation myocardial infarction (STEMI) and non ST-elevation myocardial infarction (NSTEMI).

Methods: Using data from acute coronary syndrome patients with STEMI (n = 338) and NSTEMI (n = 339) and case-crossover methods, we estimated the risk of STEMI and NSTEMI associated with increased ambient fine particle (<2.5 um) concentrations, ultrafine particle (10-100 nm) number concentrations, and accumulation mode particle (100-500 nm) number concentrations in the previous few hours and days.

Results: We found a significant 18% increase in the risk of STEMI associated with each 7.1 μg/m³ increase in PM₂.₅ concentration in the previous hour prior to acute coronary syndrome onset, with smaller, non-significantly increased risks associated with increased fine particle concentrations in the previous 3, 12, and 24 hours. We found no pattern with NSTEMI. Estimates of the risk of STEMI associated with interquartile range increases in ultrafine particle and accumulation mode particle number concentrations in the previous 1 to 96 hours were all greater than 1.0, but not statistically significant. Patients with pre-existing hypertension had a significantly greater risk of STEMI associated with increased fine particle concentration in the previous hour than patients without hypertension.

Conclusions: Increased fine particle concentrations in the hour prior to acute coronary syndrome onset were associated with an increased risk of STEMI, but not NSTEMI. Patients with pre-existing hypertension and other cardiovascular disease appeared particularly susceptible. Further investigation into mechanisms by which PM can preferentially trigger STEMI over NSTEMI within this rapid time scale is needed.

Figures

Figure 1
Figure 1
Risk (and 95% confidence interval) of STEMI and NSTEMI associated with each interquartile range increase in PM2.5concentration, by lag hours.

References

    1. Berglind N. et al.Air pollution exposure–a trigger for myocardial infarction? Int J Environ Res Public Health. 2010;7(4):1486–1499. doi: 10.3390/ijerph7041486.
    1. D’Ippoliti D. et al.Air pollution and myocardial infarction in Rome: a case-crossover analysis. Epidemiology. 2003;14(5):528–535. doi: 10.1097/01.ede.0000082046.22919.72.
    1. Mustafic H. et al.Main air pollutants and myocardial infarction: a systematic review and meta-analysis. JAMA. 2012;307(7):713–721. doi: 10.1001/jama.2012.126.
    1. Peters A. et al.Increased particulate air pollution and the triggering of myocardial infarction. Circulation. 2001;103(23):2810–2815. doi: 10.1161/01.CIR.103.23.2810.
    1. Peters A. et al.Particulate air pollution and nonfatal cardiac events. Part I. Air pollution, personal activities, and onset of myocardial infarction in a case-crossover study. Res Rep Health Eff Inst. 2005;124:1–66. discussion 67–82, 141–8.
    1. Rich DQ. et al.Triggering of transmural infarctions, but not nontransmural infarctions, by ambient fine particles. Environ Health Perspect. 2010;118(9):1229–1234. doi: 10.1289/ehp.0901624.
    1. Sullivan J. et al.Relation between short-term fine-particulate matter exposure and onset of myocardial infarction. Epidemiology. 2005;16(1):41–48. doi: 10.1097/01.ede.0000147116.34813.56.
    1. Pope CA 3rd. et al.Ischemic heart disease events triggered by short-term exposure to fine particulate air pollution. Circulation. 2006;114(23):2443–2448. doi: 10.1161/CIRCULATIONAHA.106.636977.
    1. Zanobetti A, Schwartz J. The effect of particulate air pollution on emergency admissions for myocardial infarction: a multicity case-crossover analysis. Environ Health Perspect. 2005;113(8):978–982. doi: 10.1289/ehp.7550.
    1. Dominici F. et al.Fine particulate air pollution and hospital admission for cardiovascular and respiratory diseases. JAMA. 2006;295(10):1127–1134. doi: 10.1001/jama.295.10.1127.
    1. Shah AS. et al.Global association of air pollution and heart failure: a systematic review and meta-analysis. Lancet. 2013;382(9897):1039–1048. doi: 10.1016/S0140-6736(13)60898-3.
    1. Monroe VS, Parilak LD, Kerensky RA. Angiographic patterns and the natural history of the vulnerable plaque. Prog Cardiovasc Dis. 2002;44(5):339–347. doi: 10.1053/pcad.2002.123476.
    1. Levy D. et al.Referent selection in case-crossover analyses of acute health effects of air pollution. Epidemiology. 2001;12(2):186–192. doi: 10.1097/00001648-200103000-00010.
    1. Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol. 1991;133(2):144–153.
    1. O’Gara PT. et al.ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127(4):e362–e425.
    1. Wang Y. et al.Long-term characterization of indoor and outdoor ultrafine particles at a commercial building. Environ Sci Technol. 2010;44(15):5775–5780. doi: 10.1021/es1001677.
    1. Kunzli N, Schindler C. A call for reporting the relevant exposure term in air pollution case-crossover studies. J Epidemiol Community Health. 2005;59(6):527–530. doi: 10.1136/jech.2004.027391.
    1. Manari A, Albiero R, De Servi S. High-risk non-ST-segment elevation myocardial infarction versus ST-segment elevation myocardial infarction: same behaviour and outcome? J Cardiovasc Med (Hagerstown) 2009;10(Suppl 1):S13–S16. doi: 10.2459/01.JCM.0000362039.48638.92.
    1. Polonski L. et al.A comparison of ST elevation versus non-ST elevation myocardial infarction outcomes in a large registry database: are non-ST myocardial infarctions associated with worse long-term prognoses? Int J Cardiol. 2011;152(1):70–77. doi: 10.1016/j.ijcard.2010.07.008.
    1. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation. 2001;104(3):365–372. doi: 10.1161/01.CIR.104.3.365.
    1. Latz B. et al.Postoperative nausea and vomiting in patients after craniotomy: incidence and risk factors. J Neurosurg. 2011;114(2):491–496. doi: 10.3171/2010.9.JNS10151.
    1. Rich DQ. et al.Association between changes in air pollution levels during the Beijing Olympics and biomarkers of inflammation and thrombosis in healthy young adults. JAMA. 2012;307(19):2068–2078.
    1. Stewart JC. et al.Vascular effects of ultrafine particles in persons with type 2 diabetes. Environ Health Perspect. 2010;118(12):1692–1698. doi: 10.1289/ehp.1002237.
    1. Brook RD. et al.Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation. 2010;121(21):2331–2378. doi: 10.1161/CIR.0b013e3181dbece1.
    1. Ruckerl R. et al.Ultrafine particles and platelet activation in patients with coronary heart disease–results from a prospective panel study. Part Fibre Toxicol. 2007;4:1. doi: 10.1186/1743-8977-4-1.
    1. Samet JM. et al.Concentrated ambient ultrafine particle exposure induces cardiac changes in young healthy volunteers. Am J Respir Crit Care Med. 2009;179(11):1034–1042. doi: 10.1164/rccm.200807-1043OC.
    1. U.S. EPA. Integrated Science Assessment for Particulate Matter (Final Report) Washington, DC: U.S. Environmental Protection Agency; 2009. EPA/600/R-08/139F.
    1. Nemmar A. et al.Ultrafine particles affect experimental thrombosis in an in vivo hamster model. Am J Respir Crit Care Med. 2002;166(7):998–1004. doi: 10.1164/rccm.200110-026OC.
    1. Ruckerl R. et al.Air pollution and markers of inflammation and coagulation in patients with coronary heart disease. Am J Respir Crit Care Med. 2006;173(4):432–441. doi: 10.1164/rccm.200507-1123OC.
    1. Rudez G. et al.Effects of ambient air pollution on hemostasis and inflammation. Environ Health Perspect. 2009;117(6):995–1001. doi: 10.1289/ehp.0800437.
    1. Barath S. et al.Impaired vascular function after exposure to diesel exhaust generated at urban transient running conditions. Part Fibre Toxicol. 2010;7:19. doi: 10.1186/1743-8977-7-19.
    1. Lucking AJ. et al.Diesel exhaust inhalation increases thrombus formation in man. Eur Heart J. 2008;29(24):3043–3051. doi: 10.1093/eurheartj/ehn464.
    1. Mills NL. et al.Combustion-derived nanoparticulate induces the adverse vascular effects of diesel exhaust inhalation. Eur Heart J. 2011;32(21):2660–2671. doi: 10.1093/eurheartj/ehr195.
    1. Mills NL. et al.Ischemic and thrombotic effects of dilute diesel-exhaust inhalation in men with coronary heart disease. N Engl J Med. 2007;357(11):1075–1082. doi: 10.1056/NEJMoa066314.
    1. Mills NL. et al.Diesel exhaust inhalation causes vascular dysfunction and impaired endogenous fibrinolysis. Circulation. 2005;112(25):3930–3936. doi: 10.1161/CIRCULATIONAHA.105.588962.
    1. Koltowski L. et al.IgG, IgM and inflammatory markers serum concentration in patients with acute coronary syndrome: a pilot study. Kardiol Pol. 2012;70(10):1023–1028.
    1. Di Stefano R. et al.Inflammatory markers and cardiac function in acute coronary syndrome: difference in ST-segment elevation myocardial infarction (STEMI) and in non-STEMI models. Biomed Pharmacother. 2009;63(10):773–780. doi: 10.1016/j.biopha.2009.06.004.
    1. Tekbas E. et al.Mean platelet volume in predicting short- and long-term morbidity and mortality in patients with or without ST-segment elevation myocardial infarction. Scand J Clin Lab Invest. 2011;71(7):613–619. doi: 10.3109/00365513.2011.599416.
    1. Habib SS. et al.CRP levels are higher in patients with ST elevation than non-ST elevation acute coronary syndrome. Arq Bras Cardiol. 2011;96(1):13–17. doi: 10.1590/S0066-782X2010005000161.
    1. Jeong CH. et al.Characteristics of nucleation and growth events of ultrafine particles measured in Rochester, NY. Environ Sci Technol. 2004;38(7):1933–1940. doi: 10.1021/es034811p.
    1. Toutouzas K. et al.Morphological characteristics of culprit ruptured plaques differ between NSTEMI and STEMI. Circulation. 2011;124 A15537.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere